X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
EU WC
Listed Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214463
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211065
https://www.business-standard.com/article/news-cm/strides-pharma-gets-usfda-nod-for-anti-inflammatory-drug-122081800747_1.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215472
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211360
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-29-2021-1632907538.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-8-2021-1631096882.pdf
https://www.business-standard.com/article/pti-stories/drug-makers-granules-india-jubilant-cadista-recall-products-in-us-market-121091200339_1.html
https://www.prnewswire.com/news-releases/aleve-teams-up-with-charles-barkley-and-max-homa-to-find-the-worst-golf-swing-in-america-in-support-of-the-newly-launched-topical-pain-reliever-alevex-301333797.html
https://www.prnewswire.com/news-releases/aleve-teams-up-with-charles-barkley-and-max-homa-to-find-the-worst-golf-swing-in-america-in-support-of-the-newly-launched-topical-pain-reliever-alevex-301333797.html
https://www.business-standard.com/article/markets/granules-india-up-5-on-usfda-approval-for-generic-aleve-pm-tablets-120092500500_1.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213663
https://www.biospectrumindia.com/news/43/15876/dr-reddys-laboratories-launches-delayed-release-tablets-in-the-u-s-market.html
https://business.medicaldialogues.in/pharma-news/dr-reddys-laboratories-launches-generic-of-naproxen-esomeprazole-magnesium-delayed-release-tablets-63539
https://www.prnewswire.com/news-releases/nuvo-pharmaceuticals-announces-health-canada-approves-suvexx-for-the-acute-treatment-of-migraine-301013063.html
https://www.biospace.com/article/releases/dr-reddy-s-laboratories-announces-the-first-generic-launch-of-naproxen-and-esomeprazole-magnesium-delayed-release-tablets-in-the-u-s-market/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212199
https://www.prnewswire.com/news-releases/aleve-demonstrates-more-pain-relief-than-acetaminophen-for-menstrual-cramps-study-shows-300925238.html
https://www.prnewswire.com:443/news-releases/aleve-demonstrates-more-pain-relief-than-a-commonly-prescribed-opioid-after-wisdom-tooth-extraction-studies-show-300913430.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211830
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208499
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207597
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202807
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207612
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209726
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=090872
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202803
https://www.newswire.ca/news-releases/esoph-an-innovative-therapy-for-heartburn-approved-for-canada-686799731.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207457
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-21-2018-1519194777.pdf
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-naproxen-sodium-capsules-1515129248.pdf
https://www.pharmacompass.com/pdf/news/naproxen-sodium-patheon-softgels-v-apotex-1517211100.pdf
http://khn.org/news/climbing-cost-of-decades-old-drugs-threatens-to-break-medicaid-bank/
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204872
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2016/61452r-eng.php
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/aurobindo-pharma-gets-usfda-nod-for-osteoporosis-drug/articleshow/51469929.cms
https://www.pharmacompass.com/pdf/news/aurobindo-pharmas-generic-naproxen-sodium-approved-in-us-as-nonsteroidal-anti-inflammatory-drugs-1458722420.pdf
http://www.fiercepharmamarketing.com/story/bayer-aleve-and-gsk-flonase-top-list-otc-tv-ad-spenders-2015/2016-02-22
http://www.pernixtx.com/news/fda-approves-treximet-sumatriptan-and-naproxen-sodium-for-use-in-pediatric-patients/
http://www.fiercepharma.com/story/pernix-figures-1-1-1-equals-more-three-new-zohydro-salesforce/2015-03-18
http://www.fdalawblog.net/fda_law_blog_hyman_phelps/2015/03/fdas-anti-franchising-policy-what-is-it-and-where-did-it-come-from.html
http://www.pernixtx.com/news/pernix-therapeutics-announces-fda-acceptance-with-priority-review-of-its-treximet-snda-for-use-in-adolescent-patients/
Market Place
Share 
